1021535-31-8

Basic information

• Product Name: 3-(5-amino-2-methylphenyl)-1,7-dimethyl-1,6-naphthyridin-2(1H)-one
• Synonyms: 3-(5-amino-2-methylphenyl)-1,7-dimethyl-1,6-naphthyridin-2(1H)-one;3-(5-aMino-2-Methylphenyl)-1,7-diMethyl-1,2-dihydro-1,6-naphthyridin-2-one
• CAS NO: 1021535-31-8
• Molecular Formula: C₁₇H₁₇N₃O
• Molecular Weight: 279
• Mol File: 1021535-31-8.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-(5-amino-2-methylphenyl)-1,7-dimethyl-1,6-naphthyridin-2(1H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(5-amino-2-methylphenyl)-1,7-dimethyl-1,6-naphthyridin-2(1H)-one(1021535-31-8)
• EPA Substance Registry System: 3-(5-amino-2-methylphenyl)-1,7-dimethyl-1,6-naphthyridin-2(1H)-one(1021535-31-8)

Safety Data

• Hazardous Substances Data: 1021535-31-8(Hazardous Substances Data)

Usage

General Description

3-(5-Amino-2-methylphenyl)-1,7-dimethyl-1,6-naphthyridin-2(1H)-one is a chemical compound with the molecular formula C19H19N3O. It is a naphthyridinone derivative, which is a class of compounds known for their diverse biological activities. This particular compound has been studied for its potential pharmacological properties, including its antimicrobial and antifungal activities. It exhibits a unique structural arrangement that makes it a promising candidate for the development of new drugs targeting infectious diseases. Further research and exploration of its biological and pharmacological properties are needed to fully understand its potential in the field of medicine and pharmaceuticals.

Upstream product

• 850451-77-3 3-(5-amino-2-methylphenyl)-7-chloro-1-methyl-1,6-naphthyridin-2(1H)-one 
• 75-24-1 trimethylaluminum 
• 287119-83-9 2-(2-Methyl-5-nitrophenyl)acetic acid 
• 287119-84-0 2-methyl-5-nitrophenylacetic acid methyl ester 
• 850449-93-3 methyl 2-(5-amino-2-methylphenyl)acetate 
• 105-50-0 diethyl 1,3-acetonedicarboxylate 
• 1975-52-6 5-nitro-o-toluic acid 
• 22474-47-1 (2-methyl-5-nitro-7-phenyl)methanol 
• 449811-30-7 (6-chloro-4-(methylamino)pyridin-3-yl)methanol 
• 409082-10-6 (2-methyl-5-nitrophenyl)-methyl methylsulfonate 
• 6975-44-6 4,6-dihydroxynicotinic acid ethyl ester 
• 40296-46-6 ethyl 4,6-dichloronicotinate 
• 449811-28-3 ethyl 6-chloro-4-(methylamino)pyridine-3-carboxylate 
• 449811-29-4 6-chloro-4-(methylamino)pyridine-3-carbaldehyde 

Downstream Products

• 1021531-86-1 1-(3-(1,7-dimethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-4-methylphenyl)-3-(4-methylbenzyl)urea 
• 1021532-16-0 N-(3-(1,7-dimethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-4-methylphenylcarbamoyl)-4-methoxybenzamide 
• 1021532-47-7 N-(3-(1,7-dimethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-4-methylphenylcarbamothioyl)benzamide 
• 1021535-34-1 3-bromo-5-(trifluoromethyl)-N-(3-(1,2-dihydro-1,7-dimethyl-2-oxo-1,6-naphthyridin-3-yl)-4-methylphenyl)benzamide 
• 1185855-70-2 (E)-1-(3-(1,7-dimethyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-4-methylphenyl)-2-hydroxyguanidine 
• 1185280-22-1 3-(5-(5-(1-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-ylamino)-2-methylphenyl)-1,7-dimethyl-1,6-naphthyridin-2(1H)-one 
• 1185279-84-8 1,7-dimethyl-3-(2-methyl-5-(5-(1-methylcyclopropyl)-1,2,4-oxadiazol-3-ylamino)phenyl)-1,6-naphthyridin-2(1H)-one 
• 1185281-13-3 C₂₆H₂₃N₃O₂S 
• 1185280-19-6 3-(5-(5-(1-hydroxy-2-methylpropyl)-1,2,4-oxadiazol-3-ylamino)-2-methylphenyl)-1,7-dimethyl-1,6-naphthyridin-2(1H)-one 
• 1185280-49-2 3-[5-({5-[(1S)-1-hydroxy-2-methylpropyl]-1,2,4-oxadiazol-3-yl}amino)-2-methylphenyl]-1,7-dimethyl-1,2-dihydro-1,6-naphthyridin-2-one 
• 1185281-01-9 1,7-dimethyl-3-(2-methyl-5-(5-phenyl-1,3,4-thiadiazol-2-ylamino)phenyl)-1,6-naphthyridin-2(1H)-one 
• 1185279-55-3 1,7-dimethyl-3-(2-methyl-5-(5-phenyl-1,2,4-oxadiazol-3-ylamino)phenyl)-1,6-naphthyridin-2(1H)-one 
• 1185280-04-9 1,7-dimethyl-3-(2-methyl-5-(5-(pyridin-2-yl)-1,2,4-oxadiazol-3-ylamino)phenyl)-1,6-naphthyridin-2(1H)-one 
• 1185280-97-0 1,7-dimethyl-3-(2-methyl-5-(3-(pyridin-2-yl)-1,2,4-oxadiazol-5-ylamino)phenyl)-1,6-naphthyridin-2(1H)-one 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AND COMPOSITIONS AS C-KIT AND PDGFR KINASE INHIBITORS

The invention provides a novel class of compounds of Formula I: (I) pharmaceutical compositions comprising such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of c-kit, PDGFRα and PDGFRβ kinases.